Seattle, Washington, United States · On-site
$72k–$90k/yr
Staff Accountant Position Summary: The Staff Accountant will be responsible for preparing month-end journal entries and reconciliations related to cash, prepaids, fixed assets and accruals. The Staff Accountant will also…
Skills: Month-end Closing, Journal Entries, Account Reconciliation, Fixed Assets Management, Accounts Payable
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
The Staff Accountant is responsible for preparing month-end journal entries and reconciliations for cash, prepaids, fixed assets, and accruals. Additionally, the role involves managing AP suppliers, reviewing employee expenses, and supporting SOX compliance and audit activities.
A BS degree in Business with an Accounting concentration and at least 2 years of relevant experience are required. A CPA certification and prior audit experience are preferred but not mandatory.
Staff Accountant
Position Summary: The Staff Accountant will be responsible for preparing month-end journal entries and reconciliations related to cash, prepaids, fixed assets and accruals. The Staff Accountant will also assist with setting up AP suppliers, approving employee expense reimbursement reports, and supporting ad hoc projects.
About Omeros Corporation
Omeros is an innovative biotechnology company that discovers, develops, and commercializes first-in-class small-molecule and protein therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. Omeros’ lead lectin pathway inhibitor YARTEMLEA®, which inhibits the pathway’s effector enzyme MASP-2, is FDA-approved for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA) in adult and pediatric patients ages two years and older, with a planned U.S. launch in January 2026. A marketing authorization application for YARTEMLEA in TA-TMA is currently under review by the European Medicines Agency, with a decision expected in mid-2026. OMS1029, Omeros’ long-acting MASP-2 inhibitor, has successfully completed Phase 1 clinical trials.
Under a recently announced asset purchase and licensing agreement, Novo Nordisk acquired global rights to zaltenibart (formerly OMS906), a MASP-3 inhibitor in clinical development for PNH and other alternative pathway indications, along with associated intellectual property and related assets. Omeros’ pipeline also includes OMS527, a phosphodiesterase 7 inhibitor in clinical development for cocaine use disorder and fully funded by the National Institute on Drug Abuse, as well as a growing portfolio of novel molecular and cellular oncology programs. For more information about Omeros and its programs, visit www.omeros.com.
Come be a part of Omeros, come join our Finance Team!
Essential Duties & Responsibilities:
Education, Experience, Knowledge, & Skills Required:
Behavioral Competencies Required:
Physical Demands Required:
Omeros is proud to offer a competitive total compensation package designed to support the lives of our employees and their families. The wage scale for this position is ($72,000-$90,000). Salaries will be determined based on knowledge, skills, education, and experience relevant to the role. Employees are offered medical, dental, vision, life insurance, and a 401(k) plan with a company match. Employees accrue three weeks of vacation and 80 hours of sick time on an annual basis and receive twelve paid holidays throughout the calendar year. This position is eligible for incentive and stock options. To learn more about Omeros, please visit www.omeros.com.
Omeros is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to status as a protected veteran or a qualified individual with a disability, or other protected status such as race, religion, color, national origin, sex, age, marital status, or any other factor determined to be unlawful by federal, state, or local statutes.
It is our policy to provide reasonable accommodation to anyone with a disability who needs assistance completing the job application process. If you need assistance, you can either send an e-mail to [email protected] or contact Omeros, asking for Human Resources, at (206) 676-5000.
To perform this job successfully, an individual must be able to perform each essential duty satisfactorily. The requirements listed above are representative of the knowledge, skills, and/or abilities required. Reasonable accommodations may be made to enable individuals with disabilities to perform the essential functions.
Let science lead the way
Omeros is a Seattle-based biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system.
Offices: 201 Elliott Ave W, Seattle, WA 98119, US
Let science lead the way
Omeros is a Seattle-based biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system.
Offices: 201 Elliott Ave W, Seattle, WA 98119, US
